Best World to invest in A*Star startup with an eye on stem cell-based products
Nisha Ramchandani
Singapore
BEST World International is investing in A*Star spinoff Celligenics as it seeks to leverage on synergies with its own business in the health and wellness sector.
In a filing with the Singapore Exchange on Monday, it said that it had entered into a share subscription agreement (SSA) with Celligenics.
TRENDING NOW
Why US$100 oil, 5% US yields affect Singdollar, ringgit differently vs other Asean currencies
Asia needs new energy security architecture
Despite the de-dollarisation debate, demand for dollar liquidity in Asia is growing
Anthropic to open Singapore office in October, sees it as a ‘standout market’ for Claude